Conclusions: The treatment of patients with cerebral infarction was complex, often has to combine many different classes of drugs, some have narrow therapeutic ranges, which were indicated in patients with multiple pathologies that increased the risk of drug-related problems. It is necessary to monitor closely the drug therapeutics.